22nd Century provides update on its VLN reduced nicotine tobacco products

22nd Century (XXII) announced a corporate update regarding its Modified Risk Tobacco Product, or MRTP, renewal process for its VLN reduced nicotine content products – the first and only combustible cigarette authorized by the FDA specifically to reduce the health harms of smoking, originally authorized in December 2021 and due for renewal in December 2026. Based on independent clinical research studies included in the original MRTP decision, FDA authorized VLN claims include: “95% less nicotine”, “Helps reduce your nicotine consumption”, “Greatly reduces your nicotine consumption”, “Helps you smoke less”. The renewal process is part of 22nd Century’s ongoing R&D programs that continue to advance reduced nicotine content in tobacco and support the introduction of additional VLN based products that give tobacco users further health oriented non-addictive alternatives to conventional tobacco products.